Gregoire Rotalier - Pharmagest Interactive Deputy Managing Director, Director
| PHF Stock | EUR 36.40 16.37 31.02% |
Insider
Gregoire Rotalier is Deputy Managing Director, Director of Pharmagest Interactive SA since 2020.
| Age | 49 |
| Tenure | 6 years |
| Address | 5 Allée de Saint-Cloud, Villers-les-Nancy, France, 54600 |
| Phone | 33 8 20 90 81 00 |
| Web | https://equasens.com |
Pharmagest Interactive Management Efficiency
The company has return on total asset (ROA) of 0.0704 % which means that it generated a profit of $0.0704 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1613 %, meaning that it generated $0.1613 on every $100 dollars invested by stockholders. Pharmagest Interactive's management efficiency ratios could be used to measure how well Pharmagest Interactive manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Pharmagest Interactive's Non Currrent Assets Other are most likely to increase significantly in the upcoming years. The Pharmagest Interactive's current Other Assets is estimated to increase to about 66.2 M, while Total Assets are projected to decrease to roughly 299.4 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| I Wangsawijaya | PT Bank Central | N/A | |
| Laurensius Teiseran | PT Bank Mandiri | 37 | |
| Andrijanto | PT Bank Rakyat | N/A | |
| Dedy Krisnawan | PT Bank Mandiri | N/A | |
| Agus Winardono | PT Bank Rakyat | 58 | |
| Sigit Prastowo | PT Bank Mandiri | 55 | |
| Agus Handaya | PT Bank Mandiri | 56 | |
| Yulianto Setiawan | PT Bank Rakyat | N/A | |
| Rustarti Pertiwi | PT Bank Rakyat | N/A | |
| Ahmad Lutfiyanto | PT Bank Rakyat | 56 | |
| Ida Subagia | PT Bank Rakyat | N/A | |
| Armand Hartono | PT Bank Central | 50 | |
| Toto Prasetio | PT Bank Mandiri | 57 | |
| Koes Hariyono | PT Bank Rakyat | N/A | |
| Aquarius Rudianto | PT Bank Mandiri | 59 | |
| Viviana K | PT Bank Rakyat | 48 | |
| Sunarso | PT Bank Rakyat | 60 | |
| Lay Santoso | PT Bank Central | N/A | |
| Haryanto Budiman | PT Bank Central | 55 | |
| Jahja Setiaatmadja | PT Bank Central | 67 | |
| Vera Lim | PT Bank Central | 60 | |
Management Performance
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0704 |
Pharmagest Interactive Leadership Team
Elected by the shareholders, the Pharmagest Interactive's board of directors comprises two types of representatives: Pharmagest Interactive inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pharmagest. The board's role is to monitor Pharmagest Interactive's management team and ensure that shareholders' interests are well served. Pharmagest Interactive's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pharmagest Interactive's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Dominique Pautrat, Chief Executive Officer, Member of the Executive Committee, Member of the Board of Directors | ||
| Gregoire Rotalier, Deputy Managing Director, Director | ||
| Noelle Stoulig, Head Communications | ||
| Celine Gris, Independent Director | ||
| Hugues Moreaux, Representative of La Cooperative Welcoop on the Board of Directors | ||
| Daniel Antoine, Director | ||
| Emilie Lecomte, Director | ||
| Grgoire Rotalier, Deputy CEO | ||
| Rodolphe Zimmer, Member of the Executive Committee, Director of Human Resources | ||
| Sabrina Gharbi, Chief Officer | ||
| Francois Jacquel, Director | ||
| Dominique Goursaud, Head Division | ||
| Thierry Chapusot, Chairman of the Board | ||
| Thierry Ponnelle, Deputy Chief Executive Officer, Director of Commercial Strategy and Marketing, Member of the Board of Directors, Member of the Executive Committee | ||
| Anne Lhote, Director | ||
| Sophie Mayeux, Independent Director | ||
| Denis Supplisson, Deputy Chief Executive Officer, Member of the Executive Board, Director | ||
| JeanYves Samson, Member of the Executive Committee, Director of Administration and Finance, Investor Relations Officer | ||
| Frederique Schmidt, Group Officer |
Pharmagest Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pharmagest Interactive a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.0704 | ||||
| Profit Margin | 0.16 % | ||||
| Operating Margin | 0.18 % | ||||
| Current Valuation | 557.88 M | ||||
| Shares Outstanding | 15.03 M | ||||
| Shares Owned By Insiders | 66.84 % | ||||
| Shares Owned By Institutions | 12.32 % | ||||
| Price To Earning | 53.56 X | ||||
| Price To Book | 8.09 X |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Pharmagest Stock
Pharmagest Interactive financial ratios help investors to determine whether Pharmagest Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmagest with respect to the benefits of owning Pharmagest Interactive security.